Qing Sarah Yuan
Chief Tech/Sci/R&D Officer at SIGILON THERAPEUTICS, INC.
Profile
Qing Sarah Yuan is currently the Chief Technical Operations Officer at Sigilon Therapeutics, Inc. Prior to this, she worked as the Head-Technical Development at Bioverativ, Inc. from 2017 to 2019.
She also held the position of Vice President-Process & Analytical Development at 2seventy Bio, Inc. Dr. Yuan holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of California, Berkeley.
Qing Sarah Yuan active positions
| Companies | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 06/03/2022 |
Former positions of Qing Sarah Yuan
| Companies | Position | End |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 31/12/2018 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Training of Qing Sarah Yuan
| University of Wisconsin | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Qing Sarah Yuan
